Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIPPLE-1: Evaluation of Safety and Efficacy of the IBE-814 Intravitreal Implant in Patients with Diabetic Macular Oedema and Macular Oedema Due to Retinal Vein Occlusion

NCT04576689 is registered in ClinicalTrials.gov with Ripple Therapeutics Pty Ltd as lead sponsor.

NCT NCT04576689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04576689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIPPLE-1: Evaluation of Safety and Efficacy of the IBE-814 Intravitreal Implant in Patients with Diabetic Macular Oedema and Macular Oedema Due to Retinal Vein Occlusion
Lead sponsor
Ripple Therapeutics Pty Ltd
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2020
Completion date
March 15, 2024
Enrollment
60 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular oedema, retinal vein occlusion with macular oedema